Corient Private Wealth LP Sells 98,797 Shares of Stryker Corporation $SYK

Corient Private Wealth LP reduced its position in Stryker Corporation (NYSE:SYK) by 9.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 999,514 shares of the medical technology company’s stock after selling 98,797 shares during the quarter. Corient Private Wealth LP’s holdings in Stryker were worth $314,689,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of SYK. Gables Capital Management Inc. bought a new stake in Stryker in the 2nd quarter worth approximately $25,000. Kilter Group LLC purchased a new stake in Stryker in the second quarter worth approximately $25,000. Highland Investment Advisors LLC bought a new position in Stryker during the second quarter valued at approximately $25,000. Godfrey Financial Associates Inc. bought a new position in Stryker during the fourth quarter valued at approximately $26,000. Finally, Sankala Group LLC purchased a new position in shares of Stryker during the fourth quarter worth approximately $26,000. 77.09% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on SYK shares. Wolfe Research lowered shares of Stryker from an “outperform” rating to a “peer perform” rating in a report on Thursday, August 13th. Piper Sandler decreased their target price on shares of Stryker from $420.00 to $390.00 and set an “overweight” rating on the stock in a research report on Friday, July 31st. Truist Financial lifted their target price on shares of Stryker from $330.00 to $340.00 and gave the stock a “hold” rating in a research report on Friday, July 31st. Citizens Jmp lowered their price target on shares of Stryker from $440.00 to $400.00 and set a “market outperform” rating for the company in a research note on Monday, August 3rd. Finally, BMO Capital Markets restated an “outperform” rating and set a $317.00 price target on shares of Stryker in a research report on Wednesday. Eighteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $380.40.

Insider Activity

In other news, insider Dylan Crotty sold 441 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $328.61, for a total transaction of $144,917.01. Following the completion of the transaction, the insider directly owned 6,102 shares of the company’s stock, valued at approximately $2,005,178.22. This represents a 6.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Debra King sold 826 shares of the stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total transaction of $277,783.80. Following the sale, the insider owned 6,210 shares of the company’s stock, valued at approximately $2,088,423. This represents a 11.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 351,267 shares of company stock valued at $118,197,701. Insiders own 4.60% of the company’s stock.

Stryker Stock Down 2.0%

Shares of Stryker stock opened at $269.98 on Friday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. Stryker Corporation has a 52-week low of $269.64 and a 52-week high of $392.55. The stock has a market capitalization of $103.56 billion, a price-to-earnings ratio of 27.98, a P/E/G ratio of 1.72 and a beta of 0.76. The company’s 50 day moving average price is $325.65 and its 200-day moving average price is $326.84.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating analysts’ consensus estimates of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The company had revenue of $6.59 billion during the quarter, compared to analyst estimates of $6.58 billion. During the same period in the prior year, the business posted $3.13 EPS. The firm’s revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Equities research analysts forecast that Stryker Corporation will post 15.03 EPS for the current year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.88 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.3%. Stryker’s payout ratio is presently 36.48%.

About Stryker

Stryker Corporation is a global medical technology company headquartered in Portage, Michigan. The company develops and manufactures products used by hospitals, physicians and other healthcare providers across a range of medical specialties.

Stryker’s principal businesses include orthopaedics, medical and surgical equipment, and neurovascular products. Its offerings include joint replacement and trauma implants, spinal devices, surgical instruments, operating-room equipment, endoscopy systems, surgical navigation technologies, emergency-care products and devices used to treat neurovascular conditions such as stroke.

Founded in 1941 by Dr.